HSP90B1 and neoplasm: Gp96 has been proposed to exert multiple roles in T-cell activation, with its unique ability to bind a variety of tumor-associated antigens (TAAs) and disease-associated antigens (DAAs) peptides for antigen presentation to major histocompatibility complex (MHC) molecules playing a key role in this process [12–15].